ProPhase Labs owns 50% of Phusion Laboratories LLC. Phusion Laboratories is in the early stages of developing new, effective and easy-to-use products using a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients and compounds.
The joint venture will formulate and test products to exploit market opportunities within ProPhase’s robust OTC distribution channels.
For more information on Phusion Labs, please visit www.phusionlabs.com.

.jpg)